CA2589155A1 - Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose - Google Patents

Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose Download PDF

Info

Publication number
CA2589155A1
CA2589155A1 CA002589155A CA2589155A CA2589155A1 CA 2589155 A1 CA2589155 A1 CA 2589155A1 CA 002589155 A CA002589155 A CA 002589155A CA 2589155 A CA2589155 A CA 2589155A CA 2589155 A1 CA2589155 A1 CA 2589155A1
Authority
CA
Canada
Prior art keywords
loa22
strain
leptospira
mutant
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002589155A
Other languages
English (en)
Inventor
Mathieu Picardeau
Paula Ristow
Pascale Bourhy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to CA002589155A priority Critical patent/CA2589155A1/fr
Publication of CA2589155A1 publication Critical patent/CA2589155A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA002589155A 2007-06-01 2007-06-01 Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose Abandoned CA2589155A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002589155A CA2589155A1 (fr) 2007-06-01 2007-06-01 Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002589155A CA2589155A1 (fr) 2007-06-01 2007-06-01 Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose

Publications (1)

Publication Number Publication Date
CA2589155A1 true CA2589155A1 (fr) 2008-12-01

Family

ID=40091177

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002589155A Abandoned CA2589155A1 (fr) 2007-06-01 2007-06-01 Souche attenuee de leptospira n'exprimant pas la proteine du gene loa22 et son utilisation contre la leptospirose

Country Status (1)

Country Link
CA (1) CA2589155A1 (fr)

Similar Documents

Publication Publication Date Title
Ristow et al. The OmpA-like protein Loa22 is essential for leptospiral virulence
Adler et al. Leptospira and leptospirosis
JP4179627B2 (ja) コレラワクチンとしての欠失変異体
Yan et al. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model
Toobak et al. Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice
Eko et al. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili
ES2745720T5 (es) Vectores para la transformación de Mycoplasma hyopneumoniae, cepas transformadas de M. hyopneumoniae, y uso de los mismos
WO2017187190A1 (fr) Modification génétique de bactéries commensales de l'intestin pour qu'elles expriment dans leurs vésicules de membrane externe (omv) des protéines hétérologues à administrer au tractus gastro-intestinal
Faisal et al. Leptospira: Invasion, pathogenesis and persistence
Kong et al. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar Typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen
Yan et al. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis
Lepper et al. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK)
CN111867622A (zh) 经修饰的用于治疗布鲁氏菌病的布鲁氏菌疫苗株
JP2023517684A (ja) ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン
Derakhshandeh et al. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model
JP2001186874A (ja) サルモネラワクチン
US10603370B2 (en) Compositions and methods of preparing Leptospira
CN101157907B (zh) 一种表达猪源支气管败血波氏杆菌fhaB和prn基因片段的重组猪霍乱沙门氏菌株、疫苗及应用
RU2140981C1 (ru) Авирулентный штамм vibrio cholerae не-01 серогруппы (варианты), способ получения штамма (варианты), вакцина
JP2024528169A (ja) 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
David et al. Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model
US20210283234A1 (en) Engineered salmonella serovar typhimurium strains, compositions thereof, and methods of use
Ristow et al. Weykamp da Cruz McBride F, Pereira Figueira C, Huerre M, et al.(2007) The OmpA-like protein Loa22 is essential for leptospiral virulence
CN117794565A (zh) 用于保护以对抗多种血清型的猪链球菌的疫苗
WO2017108515A1 (fr) Souches bactériennes à gram négatif modifiées et leurs utilisations

Legal Events

Date Code Title Description
FZDE Dead